Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased

Am J Gastroenterol. 2012 Sep;107(9):1443-4. doi: 10.1038/ajg.2012.181.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Inflammatory Bowel Diseases / drug therapy*
  • Melanoma / chemically induced*
  • Mercaptopurine / adverse effects*
  • Prospective Studies
  • Skin Neoplasms / chemically induced*

Substances

  • Immunosuppressive Agents
  • Mercaptopurine